Research paperAn oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy
Keywords: TNFα; tumor necrosis factor alpha; TNFR; TNF receptor; Tregs; regulatory T cells; TNFR-Fc; TNF receptor-Fc fusion protein; PK; pharmacokinetics; ConA; Concanavalin A; NKT; natural killer T cells; TCR; T-cell receptor; NASH; nonalcoholic steatohepatitis;